R. Turetskaya

发表

-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter.

I. Udalova, F. Stüber, S. Nedospasov, 1995, Journal of inflammation.

Comparative Characterization of Lymphotoxin Transcripts from Human B- and T-Cell Lines, Peripheral Lymphocytes, and Normal Tissues

A. Nordheim, S. Nedospasov, D. Kuprash, 2004, Molecular Biology.

An autocrine growth factor constitutively produced by a human lymphoblastoid B-cell line is serologically related to lymphotoxin (TNF-beta).

S. Nedospasov, R. Turetskaya, T. Seregina, 1989, Molecular immunology.

Redundancy in Tumor Necrosis Factor (TNF) and Lymphotoxin (LT) Signaling In Vivo: Mice with Inactivation of the Entire TNF/LT Locus versus Single-Knockout Mice

K. Rajewsky, K. Pfeffer, M. Marino, 2002, Molecular and Cellular Biology.

Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.

K. Rajewsky, A. Tarakhovsky, K. Pfeffer, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Highly informative typing of the human TNF locus using six adjacent polymorphic markers.

D. Chaplin, I. Udalova, S. Nedospasov, 1993, Genomics.

Genes Encoding Tumor Necrosis Factors: Genome Organization, Polymorphism, and Expression

I. Udalova, S. Nedospasov, D. Kuprash, 1992 .

DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene.

I. Udalova, S. Nedospasov, D. Kuprash, 1991, Journal of immunology.

Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.

F. Marincola, J. Gnarra, J. Taubenberger, 1994, Journal of immunology.

This information is current as Response to Lipopolysaccharide and Murine TNF Promoters in Their Similarities and Differences Between Human

D. Kwiatkowski, I. Udalova, S. Nedospasov, 1999 .

Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome.

L. Shingarova, S. Nedospasov, G. Georgiev, 1986, Cold Spring Harbor symposia on quantitative biology.

A study of rat embryo cells transformed in vitro by the bovine adenovirus type 3 (BAV-3) DNA before and after a passage in the host.

E. S. Zalmanzon, L. Grigoryeva, R. Turetskaya, 1982, Virology.

Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide.

D. Kwiatkowski, I. Udalova, S. Nedospasov, 1999, Journal of immunology.

Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages.

I. Udalova, S. Nedospasov, D. Kuprash, 1995, Oncogene.

Cloning and expression analysis of the murine lymphotoxin beta gene.

J. Green, S. Nedospasov, D. Kuprash, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus. Linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes.

D. Monos, I. Udalova, D. Gasser, 1995, Human immunology.

Epidemiology of multiple sclerosis in Russia and other countries of the former Soviet Union: investigations of environmental and genetic factors

M. Sudomoina, O. Favorova, E. Gusev, 1995, Acta neurologica Scandinavica. Supplementum.

Changes in the hemopoietic system of mice deficient for tumor necrosis factor or lymphotoxin-α

M. Drutskaya, S. Nedospasov, D. Kuprash, 2000, Bulletin of Experimental Biology and Medicine.

Susceptibility Locus for IgA Deficiency and Common Variable Immunodeficiency in the HLA-DR3, -B8, -A1 Haplotypes

R. Campbell, J. Volanakis, M. Cooper, 1998, Molecular medicine.

Genomic structure, induction, and production of TNF-beta.

N. Ruddle, S. Fashena, R. Turetskaya, 1992, Immunology series.

Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation.

S. Nedospasov, D. Kuprash, A. Biragyn, 1996, Journal of immunology.